Nine departments jointly issued the "14th Five-Year Plan for Pharmaceutical Industry Development", focusing on the development of stem cells, immune cells and gene therapy products!
2022-03-04Recently, nine departments including the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Commerce, the Health and Health Commission, the Ministry of Emergency Management, the National Medical Insurance Administration, the State Food and Drug Administration, and the State Administration of Traditional Chinese Medicine jointly issued the "Fourteenth". Five "Pharmaceutical Industry Development Plan" (hereinafter referred to as the "Plan").
The Plan highlights key development tasks. On the basis of benchmarking against important documents such as the national "14th Five-Year Plan", the "Plan" focuses on the high-quality development of the industry, adheres to the problem orientation, and separates key tasks such as industrial innovation, industrial chain, supply guarantee, manufacturing capacity, and international competition. In this article , the key tasks for promoting the development of the pharmaceutical industry during the "14th Five-Year Plan" period are put forward.
Among them, the "Planning" clearly states in column 1 of "Strengthening Key Core Technology Research" in the "Accelerating Product Innovation and Industrialization Technology Breakthrough" chapter: focus on the development of chimeric antigen receptor T cells (CARs) targeting new targets and new indications. -T), chimeric antigen receptor NK cells (CAR-NK) and other immune cell therapy, stem cell therapy, gene therapy products and specific immunoglobulins, etc.
The "Planning" clearly states in column 2 of "Improving the Level of Industrialization Technology" in the chapter "Accelerating Product Innovation and Industrialization Technology Breakthrough": focus on the development of ultra-large-scale (≥10,000 liters/tank) cell culture technology, bifunctional antibodies, antibodies Industrialized preparation technology of new biological drugs such as drug conjugates, polypeptide drug conjugates, new recombinant protein vaccines, nucleic acid vaccines, cell therapy and gene therapy drugs, new biopharmaceutical drug delivery methods and new delivery technologies, and new vaccine adjuvants .
News source: official website of the Ministry of Industry and Information Technology of the People's Republic of China
